Clinical Trial: ctDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study)

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07597252) titled 'ctDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study)' on May 09.

Brief Summary: Pancreatic ductal adenocarcinoma (PDAC) carries one of the worst prognoses among solid tumors. Even after curative-intent resection, 70-80% of patients recur within two years. Current post-operative surveillance relies on computed tomography (CT) imaging and the serum tumor marker CA 19-9, but both have limited sensitivity for detecting microscopic residual disease.

This single-center, prospective observational study evaluates the use of the K-4CARE Lite platform-a tumor-informed plus tumor-agnostic circulating tumor DNA (ctDNA) assay wi...